Professor Andreas Suhrbier is head of The Immunovirology Laboratory at QIMR, and is a PRF with the NH&MRC.

The group works on various aspects of inflammation, with current projects involving chikungunya virus arthritis, SerpinB2 (aka PAI-2), and Sin1.

We also have close links with industry and are active in the generation of intellectual property.

We are currently collaborating with Leo Pharma (ingenol mebutate) and CBio (chaperonin 10).

More information about Andrews Suhrbier

Publications by Andreas Suhrbier